Biotech

Biotech & Healthcare News

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech

Top news of the week: 14.12.2021.

#COVID19coronavirus
#Conditions
#biotechnology
#hVIVO
#Influenza
#contract
#antiviral
#challengestudy
#ORPH

Healthcare

@adamfeuerstein shared
On Dec 9, 2021
Last-gasp gene therapy saved a Syrian refugee’s life. Five years later, the boy is thriving and a clinical trial is starting https://t.co/4O6HVlqbYE via @MeganMolteni
Open
Last-gasp gene therapy saved a Syrian refugee’s life. Five years later, the boy is thriving and a clinical trial is starting

Last-gasp gene therapy saved a Syrian refugee’s life. Five years later, the boy is thriving and a clinical trial is starting

Positive follow-up data has helped move forward a clinical trial of the approach, offering hope to the 500,000 epidermolysis bullosa patients.

@CR_UK shared
On Dec 11, 2021
As news of the Omicron variant continues to develop, the Government has accepted advice from the JCVI on immediate measures to be taken within the COVID-19 vaccine programmes. Find out more on the updated advice here: https://t.co/vz40sMYlA2
Open
COVID-19 vaccine and cancer – latest updates

COVID-19 vaccine and cancer – latest updates

Recently, news of a COVID-19 vaccine has dominated headlines. We've summarised all the information that is out there, with rolling updates, in our new vaccine blog post.

@kevinmd shared
On Dec 8, 2021
The American public deserves more COVID-19 vaccine options https://t.co/z7FlF4lm4N #Conditions #COVID19coronavirus via @kevinmd
Open
The American public deserves more COVID-19 vaccine options

The American public deserves more COVID-19 vaccine options

The public's trust in the public health guidance from institutions at the federal level is critical in fighting the pandemic, which is now unfortunately too politicized. Pfizer CEO Albert ...

@SWLifeSciences shared
On Dec 14, 2021
Target Price Raised on Biotech Based on Management Update: https://t.co/4yicvQZCSr Prometheus Biosciences announced new strong trial data, another new indication for its lead therapeutic candidate and progress in developing a subcutaneous formulation. $RXDX @PrometheusBio
Open
Target Price Raised on Biotech Based on Management Update Research Report

Target Price Raised on Biotech Based on Management Update Research Report

Prometheus Biosciences' news included strong trial data and another indication for its lead therapeutic candidate, according to an Oppenheimer report.

@MEDiSTRAVA_Cons shared
On Dec 10, 2021
RT @VennLifeScience: Our sister company @hVIVO_UK has signed a $13.4m #contract with a US-based #biotechnology company to test its novel #antiviral candidate using the #hVIVO #Influenza human #challengestudy model. https://t.co/E1wCmmW7oS #hVIVO #ORPH https://t.co/5i1XuQyB35
Open
$13.4m Influenza HCS contract win

$13.4m Influenza HCS contract win

$13.4m Influenza human challenge study contract win Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in vaccine and …

Read more: Healthcare
weekly 14.12.2021
View archives
Back to home

Subscribe to Biotech - Biotech & Healthcare.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech - Biotech & Healthcare.
Privacy Policy

Sign up for the weekly Biotech - Biotech & Healthcare newsletter

Never again miss anything or anyone that matter in Biotech

Sign up and receive the Biotech - Biotech & Healthcare weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy